NCT01166113
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- AOU Città della Salute e della Scienza di Torino - SC Ematologia U Torino, Italy
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,018 public trials
2,029 recruiting studies
Immunoproliferative Disorders trial results
NCT01348919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Teva Investigational Site 1 Augusta, Georgia, United States
- Teva Investigational Site 3 Lexington, Kentucky, United States
- Teva Investigational Site 2 Houston, Texas, United States
- Teva Investigational Site 201 Auckland, New Zealand
NCT04562792
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Children's Mercy Hospital Kansas City, Missouri, United States
NCT01754857
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT04950998
- Conditions
- Behavior, Brain Diseases, Central Nervous System Diseases, +22 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Conditions
- Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Columbia University Medical Center New York, United States
NCT05918809
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT05448196
- Conditions
- Behavior, Behavioral Symptoms, Blood Protein Disorders, +16 more
- Locations
-
- Penn Medicine Philadelphia, Pennsylvania, United States
NCT03364231
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
- TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
- TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
- TG Therapeutics Investigational Trial Site New York, United States
Completed
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
NCT01029366
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +45 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States